BOSTON SCIENTIFIC CORP

BSX

BOSTON SCIENTIFIC CORP

BSX

Insider Sentiment (TTM):

Last Purchase:2026-05-20Last Sale:2026-02-02Shares Purchased (TTM):7,600Shares Sold (TTM):414,220

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:1,256,844,528Shares Outstanding:1,484,900,000Institutional Ownership Pct.:84.64%

Earnings Market Reaction:

Filing Date:2026-05-01Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Surgical & Medical Instruments & Apparatus

SYK MMM BDX IDXG MDLN RMD

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	1,453	1,965	1,275	534	725	414	2,502	2,913	2,329	865	952	426
Accounts Notes And Loans Receivable Net Current	3,027	2,926	2,828	2,815	2,693	2,558	2,501	2,400	2,304	2,228	2,101	2,134
Inventory Net	3,117	2,943	2,921	2,861	2,867	2,810	2,753	2,608	2,561	2,484	2,404	2,250
Prepaid Taxes	358	299	310	298	294	307	332	315	319	315	307	303
Prepaid Expense And Other Assets Current	729	660	701	613	756	831	674	756	671	621	741	773
Assets Current	8,684	8,794	8,035	7,121	7,335	6,920	8,761	8,991	8,185	6,514	6,504	5,886
Property Plant And Equipment And Finance Lease Rig…	4,063	4,036	3,795	3,461	3,389	3,294	3,072	2,951	2,897	2,859	2,635	2,534
Goodwill	18,536	18,282	18,214	18,076	17,340	17,089	15,033	14,397	14,361	14,387	13,608	13,659
Intangible Assets Net Excluding Goodwill	7,060	7,019	7,162	7,260	6,566	6,684	5,754	5,417	5,839	6,003	5,849	6,063
Deferred Income Tax Assets Net	3,953	3,675	3,669	3,778	3,676	3,655	3,816	3,801	3,792	3,841	3,840	3,865
Other Assets Noncurrent	2,054	1,866	1,832	1,864	1,834	1,754	1,642	1,551	1,596	1,531	1,605	1,595
Assets	44,351	43,673	42,707	41,559	40,140	39,395	38,078	37,108	36,669	35,136	34,043	33,601
Liabilities And Stockhold…
Liabilities Current
Debt Current	41	299	483	480	777	1,778	1,652	1,580	1,085	531	513	559
Accounts Payable Current	1,141	1,144	1,002	962	1,004	960	907	906	921	942	929	899
Accrued Liabilities Current	2,514	3,201	2,981	2,797	2,354	2,773	2,460	2,320	2,083	2,646	2,255	2,164
Other Liabilities Current	875	795	862	952	923	887	891	770	827	814	882	940
Liabilities Current	4,571	5,439	5,328	5,190	5,058	6,399	5,910	5,576	4,916	4,933	4,579	4,562
Long Term Debt And Capital Lease Obligations	10,988	11,137	11,117	11,107	10,532	8,968	9,233	8,991	9,534	8,571	8,386	8,494
Deferred Income Tax Liabilities Net	219	220	242	226	158	155	138	132	132	134	91	135
Other Liabilities Noncurrent	2,469	2,405	2,390	2,383	1,946	1,870	1,841	1,800	1,919	1,967	1,858	1,926
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	17	17	17	17	17	17	17	17	17	17	17	17
Treasury Stock Value	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251
Additional Paid In Capital Common Stock	21,584	21,505	21,419	21,230	21,127	21,056	20,963	20,803	20,713	20,647	20,573	20,441
Retained Earnings Accumulated Deficit	6,912	5,571	4,899	4,144	3,347	2,673	2,107	1,639	1,314	819	315	-189
Accumulated Other Comprehensive Income Loss Net Of…	-398	-610	-689	-722	-28	275	-128	164	132	49	231	208
Stockholders Equity	26,104	24,472	23,394	22,653	22,446	22,003	20,708	20,371	19,926	19,530	18,886	18,226
Minority Interest	240	239	236	235	233	233	248	238	242	248	243	259
Liabilities And Stockholders Equity	44,351	43,673	42,707	41,559	40,140	39,395	38,078	37,108	36,669	35,136	34,043	33,601
Preferred Stock Par Or Stated Value Per Share	0.01	-	0.01	0.01	0.01	-	0.01	0.01	0.01	-	0.01	0.01
Preferred Stock Shares Authorized	50	-	50	50	50	-	50	50	50	-	50	50
Preferred Stock Shares Issued	0	-	0	0	0	-	0	0	0	-	0	0
Common Stock Par Or Stated Value Per Share	0.01	-	0.01	0.01	0.01	-	0.01	0.01	0.01	-	0.01	0.01
Common Stock Shares Authorized	2,000	-	2,000	2,000	2,000	-	2,000	2,000	2,000	-	2,000	2,000
Common Stock Shares Issued	-	-	1,746	1,744	1,742	-	-	1,734	-	-	1,728	1,726
Treasury Stock Common Shares	263	-	263	263	263	-	263	263	263	-	263	263

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	2.27%	-19.84%	-22.07%	-	-	-	-	-	-	-	-	-
2025	1.27%	-1.83%	0.44%	0.72%	-7.19%	-5.85%	3.03%	-2.57%	-6.17%	-9.39%	-19.01%	-29.31%
2024	4.74%	7.62%	7.41%	5.34%	11.66%	17.18%	7.63%	6.37%	17.99%	-7.77%	-11.09%	-2.36%
2023	-1.69%	3.91%	2.35%	-0.24%	5.35%	-1.63%	7.68%	8.21%	17.96%	0.02%	2.79%	11.28%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.90	1.62	1.51	1.37	1.45	1.08	1.48	1.61	1.66	1.32	1.42	1.29
Quick Ratio	1.06	0.95	0.83	0.70	0.73	0.51	0.90	1.01	1.01	0.69	0.73	0.63
Working Capital	4.11B	3.36B	2.71B	1.93B	2.28B	521.00M	2.85B	3.42B	3.27B	1.58B	1.93B	1.32B
Leverage & Debt
Debt to Equity	0.18	0.22	0.23	0.23	0.23	0.29	0.28	0.27	0.25	0.25	0.24	0.25
Interest Coverage TTM	10.62	10.35	10.22	9.51	8.96	8.53	8.69	8.96	9.17	8.84	8.15	6.97
Debt Ratio	0.10	0.12	0.12	0.12	0.13	0.16	0.16	0.15	0.13	0.14	0.13	0.14
Efficiency & Turnover
Asset Turnover TTM	0.49	0.48	0.48	0.47	0.46	0.45	0.44	0.43	0.42	0.42	0.42	0.41
Days Sales Outstanding TTM	50.64	49.86	50.26	51.46	51.95	52.16	52.79	54.34	54.35	53.80	52.69	55.17
Receivables Turnover TTM	7.21	7.32	7.26	7.09	7.03	7.00	6.91	6.72	6.72	6.78	6.93	6.62
Per Share Metrics
Diluted EPS TTM	2.38	1.94	1.86	1.67	1.36	1.24	1.21	1.24	1.21	1.09	0.80	0.59
Free Cash Flow Per Share TTM	2.34	2.47	2.58	2.35	2.04	1.80	1.46	1.25	1.16	1.23	1.16	1.04
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.02	0.03	0.04
Margin Metrics
Gross Profit Margin TTM	69.17%	69.01%	68.58%	68.27%	68.66%	68.61%	68.98%	68.97%	69.32%	69.49%	69.41%	69.51%
Operating Profit Margin TTM	18.40%	18.00%	17.90%	17.02%	16.23%	15.54%	15.79%	16.23%	16.77%	16.45%	15.71%	13.63%
Net Profit Margin TTM	17.28%	14.44%	14.40%	13.52%	11.54%	11.02%	11.33%	12.08%	12.15%	11.18%	8.53%	6.39%
Growth Metrics
Net Revenue Growth (1Y)	17.43%	19.87%	21.63%	21.45%	19.36%	17.61%	15.65%	13.64%	12.74%	12.29%	9.47%	8.69%
Net Income Growth (1Y)	75.95%	56.99%	54.66%	35.94%	13.32%	15.95%	53.62%	114.84%	114.78%	147.98%	91.98%	3.38%
EPS Growth (1Y)	75.04%	56.04%	53.72%	35.09%	12.64%	14.50%	52.77%	111.27%	110.02%	144.14%	87.67%	2.20%
Valuation Metrics
P/E TTM	26.15	48.71	51.90	63.58	73.59	71.20	68.49	61.58	56.28	52.76	65.92	91.38
P/B TTM	3.57	5.77	6.18	7.02	6.64	5.97	5.89	5.50	5.05	4.30	4.04	4.29
P/S TTM	4.52	7.03	7.48	8.59	8.49	7.85	7.76	7.44	6.84	5.90	5.62	5.84
Market Cap	93.18B	141.16B	144.66B	158.96B	149.02B	131.43B	123.41B	113.25B	100.57B	84.00B	77.33B	78.22B
Enterprise Value	102.56B	150.63B	154.98B	170.01B	159.41B	141.57B	131.65B	120.76B	108.86B	92.04B	85.27B	86.85B
Calculated Values
Free Cash Flow TTM	3.48B	3.66B	3.82B	3.49B	3.01B	2.65B	2.16B	1.84B	1.70B	1.79B	1.70B	1.51B
Net Debt	9.39B	9.47B	10.33B	11.05B	10.39B	10.14B	8.24B	7.51B	8.29B	8.05B	7.95B	8.63B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Insider Transactions

2026-05-20Purchase

Owner: Ludwig, Edward J

Title: -

Shares: 3,580

Price/Share: $56.68

Value: $202,914.40

Shares Owned: 25,359

Relationship: Director

Ownership: Direct

2026-05-20Purchase

Owner: Pegus, Cheryl

Title: -

Shares: 1,770

Price/Share: $56.49

Value: $99,987.30

Shares Owned: 1,770

Relationship: Director

Ownership: Direct

2026-05-20Purchase

Owner: Habiger, David C

Title: -

Shares: 2,250

Price/Share: $55.92

Value: $125,820.00

Shares Owned: 13,878

Relationship: Director

Ownership: Direct

2026-02-02Sale

Owner: Mahoney, Michael F

Title: Chairman, President & CEO

Shares: 160,901

Price/Share: $93.78

Value: $15,089,295.78

Shares Owned: 1,411,735

Relationship: Director,Officer

Ownership: Direct

2025-12-01Sale

Owner: Butcher, Arthur C

Title: EVP& Grp Pres, MedSurg & APAC

Shares: 17,313

Price/Share: $101.55

Value: $1,758,135.15

Shares Owned: 23,600

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-20	Ludwig, Edward J	Director	-	Direct	Purchase	3,580	56.68	$202,914.40	25,359	4
2026-05-20	Pegus, Cheryl	Director	-	Direct	Purchase	1,770	56.49	$99,987.30	1,770	4
2026-05-20	Habiger, David C	Director	-	Direct	Purchase	2,250	55.92	$125,820.00	13,878	4
2026-02-02	Mahoney, Michael F	Director,Officer	Chairman, President & CEO	Direct	Sale	160,901	93.78	$15,089,295.78	1,411,735	4
2025-12-01	Butcher, Arthur C	Officer	EVP& Grp Pres, MedSurg & APAC	Direct	Sale	17,313	101.55	$1,758,135.15	23,600	4
2025-11-06	Zane, Ellen M	Director	-	Direct	Sale	12,891	98.28	$1,266,927.48	24,134	4
2025-11-03	Fitzgerald, Joseph Michae…	Officer	EVP & Group Pres, Cardiology	Direct	Sale	50,000	99.88	$4,994,000.00	178,342	4
2025-10-28	Zane, Ellen M	Director	-	Direct	Sale	2,901	102.24	$296,598.24	24,134	4
2025-10-01	Fitzgerald, Joseph Michae…	Officer	EVP & Group Pres, Cardiology	Direct	Sale	50,000	98.64	$4,932,000.00	178,342	4
2025-09-02	Fitzgerald, Joseph Michae…	Officer	EVP & Group Pres, Cardiology	Direct	Sale	50,000	105.37	$5,268,500.00	178,342	4
2025-08-01	Butcher, Arthur C	Officer	EVP& Grp Pres, MedSurg & APAC	Direct	Sale	17,313	104.63	$1,811,459.19	23,600	4
2025-08-01	Fitzgerald, Joseph Michae…	Officer	EVP & Group Pres, Cardiology	Direct	Sale	50,000	104.63	$5,231,500.00	178,342	4
2025-07-29	Fujimori, Yoshiaki	Director	-	Direct	Sale	2,901	106.99	$310,377.99	2,081	4
2025-07-25	Ludwig, Edward J	Director	-	Direct	Sale	4,000	106.03	$424,120.00	18,479	4
2025-07-01	Fitzgerald, Joseph Michae…	Officer	EVP & Group Pres, Cardiology	Direct	Sale	50,000	106.97	$5,348,500.00	178,342	4
2025-06-04	Fitzgerald, Joseph Michae…	Officer	EVP & Group Pres, Cardiology	Direct	Sale	56,372	102.88	$5,799,551.36	178,342	4
2025-06-02	Mahoney, Michael F	Director,Officer	Chairman, President & CEO	Direct	Sale	164,443	103.72	$17,056,027.96	1,476,882	4
2025-05-29	Ludwig, Edward J	Director	-	Direct	Sale	4,000	104.59	$418,360.00	22,479	4
2025-05-21	Brown, Vance R	Officer	SVP, GC and Corp. Secretary	Direct	Sale	4,826	106.42	$513,582.92	31,367	4
2025-05-05	Sorenson, John Bradley	Officer	EVP, Global Operations	Direct	Sale	4,572	104.54	$477,956.88	18,705	4
2025-05-01	Mahoney, Michael F	Director,Officer	Chairman, President & CEO	Direct	Sale	164,443	102.52	$16,858,696.36	1,535,706	4
2025-05-01	Butcher, Arthur C	Officer	EVP& Grp Pres, MedSurg & APAC	Direct	Sale	17,314	102.06	$1,767,066.84	22,235	4
2025-04-21	Brown, Vance R	Officer	SVP, GC and Corp. Secretary	Direct	Sale	4,826	95.09	$458,904.34	36,193	4
2025-04-01	Mahoney, Michael F	Director,Officer	Chairman, President & CEO	Direct	Sale	164,442	100.01	$16,445,844.42	1,594,530	4
2025-03-21	Brown, Vance R	Officer	SVP, GC and Corp. Secretary	Direct	Sale	4,826	100.85	$486,702.10	41,019	4
2025-03-04	Woodworth, Emily	Officer	SVP, Global Controller and CAO	Direct	Sale	482	104.63	$50,431.66	432	4
2025-02-28	Woodworth, Emily	Officer	SVP, Global Controller and CAO	Direct	Sale	9,887	101.13	$999,872.31	1,632	4
2025-02-25	Mirviss, Jeffrey B.	Officer	EVP&Pres, Periph Intervent	Direct	Sale	2,688	104.00	$279,552.00	25,766	4
2025-02-24	Zane, Ellen M	Director	-	Direct	Sale	13,586	104.23	$1,416,068.78	34,944	4
2025-02-21	Brown, Vance R	Officer	SVP, GC and Corp. Secretary	Direct	Sale	4,826	104.64	$504,992.64	45,845	4
2025-02-19	Brennan, Daniel J.	Officer	EVP and CFO	Direct	Sale	67,333	105.24	$7,086,124.92	225,808	4
2025-02-19	Sorenson, John Bradley	Officer	EVP, Global Operations	Direct	Sale	3,303	105.19	$347,442.57	20,991	4
2025-02-19	Mirviss, Jeffrey B.	Officer	EVP&Pres, Periph Intervent	Direct	Sale	1,510	105.35	$159,078.50	33,129	4
2025-02-14	Sorenson, John Bradley	Officer	EVP, Global Operations	Direct	Sale	1,201	106.31	$127,678.31	25,443	4
2025-02-12	Mirviss, Jeffrey B.	Officer	EVP&Pres, Periph Intervent	Direct	Sale	13,022	105.06	$1,368,091.32	28,454	4
2025-02-12	Brennan, Daniel J.	Officer	EVP and CFO	Direct	Sale	15,087	105.07	$1,585,191.09	241,451	4
2025-02-12	Sorenson, John Bradley	Officer	EVP, Global Operations	Direct	Sale	6,389	105.06	$671,228.34	24,293	4
2025-02-11	Ludwig, Edward J	Director	-	Direct	Sale	12,000	105.48	$1,265,760.00	24,398	4
2025-02-07	Sorenson, John Bradley	Officer	EVP, Global Operations	Direct	Sale	6,528	104.97	$685,244.16	26,449	4
2025-02-03	Butcher, Arthur C	Officer	EVP& Grp Pres, MedSurg & APAC	Direct	Sale	17,313	101.80	$1,762,463.40	5,502	4
2025-01-03	Mirviss, Jeffrey B.	Officer	EVP&Pres, Periph Intervent	Direct	Sale	7,152	89.86	$642,678.72	28,454	4
2025-01-03	Sorenson, John Bradley	Officer	EVP, Global Operations	Direct	Sale	2,342	89.86	$210,452.12	32,977	4
2025-01-03	Brennan, Daniel J.	Officer	EVP and CFO	Direct	Sale	9,689	89.86	$870,653.54	223,921	4
2024-12-10	Fitzgerald, Joseph Michae…	Officer	EVP & Group Pres, Cardiology	Direct	Sale	20	89.97	$1,799.40	148,148	4
2024-12-03	Fitzgerald, Joseph Michae…	Officer	EVP & Group Pres, Cardiology	Direct	Purchase	50	90.29	$4,514.50	148,168	4
2024-12-02	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	6,983	90.78	$633,916.74	29,308	4
2024-11-27	Woodworth, Emily	Officer	SVP, Global Controller and CAO	Direct	Sale	1,336	90.65	$121,108.40	2,957	4
2024-11-25	Butcher, Arthur C	Officer	EVP& Grp Pres, MedSurg & APAC	Direct	Sale	14,010	89.27	$1,250,672.70	978	4
2024-11-21	Ludwig, Edward J	Director	-	Direct	Sale	4,877	91.63	$446,879.51	39,398	4
2024-11-08	Sorenson, John Bradley	Officer	EVP, Global Operations	Direct	Sale	30,580	87.66	$2,680,642.80	39,706	4
2024-11-05	Mahoney, Michael F	Director,Officer	Chairman, President & CEO	Direct	Sale	162,778	84.96	$13,829,618.88	1,521,205	4
2024-11-01	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	6,983	84.33	$588,876.39	32,028	4
2024-10-07	Fitzgerald, Joseph Michae…	Officer	EVP & Group Pres, Cardiology	Direct	Sale	132,527	85.00	$11,264,795.00	160,467	4
2024-10-07	Mahoney, Michael F	Director,Officer	Chairman, President & CEO	Direct	Sale	162,777	84.62	$13,774,189.74	1,572,096	4
2024-10-01	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	6,983	83.86	$585,594.38	34,748	4
2024-09-05	Mahoney, Michael F	Director,Officer	Chairman, President & CEO	Direct	Sale	162,777	81.17	$13,212,609.09	1,622,987	4
2024-09-03	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	6,983	81.70	$570,511.10	37,468	4
2024-08-28	Fitzgerald, Joseph Michae…	Officer	EVP & Group Pres, Cardiology	Direct	Sale	14,132	80.00	$1,130,560.00	176,355	4
2024-08-26	Butcher, Arthur C	Officer	EVP& Grp Pres, MedSurg & APAC	Direct	Sale	14,012	79.25	$1,110,451.00	10,802	4
2024-08-01	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	6,983	74.12	$517,579.96	40,188	4
2024-07-01	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	6,983	77.30	$539,785.90	42,908	4
2024-06-03	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	6,983	75.33	$526,029.39	45,628	4
2024-05-29	Mirviss, Jeffrey B.	Officer	EVP&Pres, Periph Intervent	Direct	Sale	63,802	75.10	$4,791,530.20	28,022	4
2024-05-28	Butcher, Arthur C	Officer	EVP& Grp Pres, MedSurg & APAC	Direct	Sale	14,011	75.34	$1,055,588.74	20,197	4
2024-05-23	Brennan, Daniel J.	Officer	EVP and CFO	Direct	Sale	47,621	75.11	$3,576,813.31	223,921	4
2024-05-22	Brown, Vance R	Officer	SVP, GC and Corp. Secretary	Direct	Sale	15,006	76.01	$1,140,606.06	32,326	4
2024-05-10	Thepaut, Eric Francis Yve…	Officer	EVP & Pres, Eur, Mid-East, Afr	Direct	Sale	12,931	74.14	$958,704.34	31,422	4
2024-05-07	Dockendorff, Charles J	Director	-	Direct	Sale	3,946	72.70	$286,874.20	0	4
2024-05-01	Sorenson, John Bradley	Officer	EVP, Global Operations	Direct	Sale	17,587	71.50	$1,257,470.50	50,638	4
2024-05-01	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	6,983	71.47	$499,075.01	48,348	4
2024-04-26	Ludwig, Edward J	Director	-	Direct	Sale	9,818	73.29	$719,561.22	41,374	4
2024-04-01	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	6,983	68.42	$477,776.86	51,068	4
2024-04-01	Sorenson, John Bradley	Officer	EVP, Global Operations	Direct	Sale	16,351	69.30	$1,133,124.30	50,638	4
2024-03-18	Mirviss, Jeffrey B.	Officer	EVP&Pres, Periph Intervent	Direct	Sale	14,506	66.45	$963,923.70	58,098	4
2024-03-01	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	6,983	66.35	$463,322.05	53,788	4
2024-02-26	Butcher, Arthur C	Officer	EVP& Grp Pres, MedSurg & APAC	Direct	Sale	9,335	67.07	$626,098.45	28,937	4
2024-02-23	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	6,983	66.89	$467,092.87	56,508	4
2024-02-21	Mirviss, Jeffrey B.	Officer	EVP&Pres, Periph Intervent	Direct	Sale	4,960	66.35	$329,096.00	72,604	4
2024-02-20	Brennan, Daniel J.	Officer	EVP and CFO	Direct	Sale	13,662	65.86	$899,779.32	271,542	4
2024-02-13	Ludwig, Edward J	Director	-	Direct	Sale	7,000	65.03	$455,210.00	41,374	4
2024-01-12	Fitzgerald, Joseph Michae…	Officer	EVP & Group Pres, Cardiology	Direct	Sale	11,660	60.00	$699,600.00	173,472	4
2024-01-09	Mirviss, Jeffrey B.	Officer	EVP&Pres, Periph Intervent	Direct	Sale	15,172	59.25	$898,941.00	56,588	4
2024-01-04	Mirviss, Jeffrey B.	Officer	EVP&Pres, Periph Intervent	Direct	Sale	15,000	58.40	$876,000.00	56,588	4
2024-01-03	Mirviss, Jeffrey B.	Officer	EVP&Pres, Periph Intervent	Direct	Sale	11,931	57.82	$689,850.42	56,588	4
2023-12-29	Fitzgerald, Joseph Michae…	Officer	EVP & Group Pres, Cardiology	Direct	Sale	81,940	57.50	$4,711,550.00	174,241	4
2023-12-15	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	11,672	55.61	$649,079.92	41,269	4
2023-12-06	Mirviss, Jeffrey B.	Officer	EVP&Pres, Periph Intervent	Direct	Sale	353	55.03	$19,425.59	56,588	4
2023-11-20	Butcher, Arthur C	Officer	EVP& Grp Pres, MedSurg & APAC	Direct	Sale	8,278	54.06	$447,508.68	6,977	4
2023-11-15	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	11,671	54.17	$632,218.07	46,532	4
2023-11-06	Mahoney, Michael F	Director,Officer	Chairman, President & CEO	Direct	Sale	113,356	52.51	$5,952,323.56	1,498,922	4
2023-10-16	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	11,671	49.79	$581,099.09	51,795	4
2023-10-09	Mahoney, Michael F	Director,Officer	Chairman, President & CEO	Direct	Sale	113,355	52.09	$5,904,661.95	1,498,922	4
2023-09-20	Fitzgerald, Joseph Michae…	Officer	EVP & Group Pres, Cardiology	Direct	Sale	15,867	55.00	$872,685.00	197,992	4
2023-09-15	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	11,671	53.95	$629,650.45	57,058	4
2023-09-12	Mahoney, Michael F	Director,Officer	Chairman, President & CEO	Direct	Sale	113,355	53.91	$6,110,968.05	1,498,922	4
2023-08-29	Mirviss, Jeffrey B.	Officer	EVP&Pres, Periph Intervent	Direct	Sale	4,657	54.50	$253,806.50	60,588	4
2023-08-25	Brown, Vance R	Officer	SVP, GC and Corp. Secretary	Direct	Sale	15,750	50.52	$795,690.00	28,578	4
2023-08-21	Butcher, Arthur C	Officer	EVP& Grp Pres, MedSurg & APAC	Direct	Sale	6,600	50.40	$332,640.00	11,396	4
2023-08-18	Dockendorff, Charles J	Director	-	Direct	Sale	17,079	50.74	$866,588.46	3,946	4
2023-08-15	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	11,671	51.30	$598,722.30	62,321	4
2023-07-17	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	11,671	52.85	$616,812.35	67,584	4
2023-06-21	Butcher, Arthur C	Officer	EVP& Grp Pres, MedSurg & APAC	Direct	Sale	6,697	53.80	$360,298.60	17,453	4
2023-06-15	Carruthers, Wendy	Officer	EVP, Human Resources	Direct	Sale	11,671	53.24	$621,364.04	72,847	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Institutional Ownership

No data available for chart

2026-03-31

84.64%

Inst. Shares: 1,256,844,528

Shares Outstanding: 1,484,900,000

2025-12-31

87.50%

Inst. Shares: 1,295,361,674

Shares Outstanding: 1,480,400,000

2025-09-30

85.90%

Inst. Shares: 1,272,810,615

Shares Outstanding: 1,481,700,000

2025-06-30

85.74%

Inst. Shares: 1,268,879,899

Shares Outstanding: 1,479,900,000

2025-03-31

83.91%

Inst. Shares: 1,239,465,746

Shares Outstanding: 1,477,200,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	1,256,844,528	1,484,900,000	84.64%
2025-12-31	1,295,361,674	1,480,400,000	87.50%
2025-09-30	1,272,810,615	1,481,700,000	85.90%
2025-06-30	1,268,879,899	1,479,900,000	85.74%
2025-03-31	1,239,465,746	1,477,200,000	83.91%
2024-12-31	1,260,913,316	1,471,500,000	85.69%
2024-09-30	1,228,702,035	1,472,700,000	83.43%
2024-06-30	1,246,520,533	1,470,600,000	84.76%
2024-03-31	1,224,342,145	1,468,400,000	83.38%
2023-12-31	1,250,110,456	1,453,000,000	86.04%
2023-09-30	1,233,366,139	1,464,500,000	84.22%
2023-06-30	1,217,059,365	1,446,200,000	84.16%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

BOSTON SCIENTIFIC CORP (BSX) — SEC Financial Statements & Analysis

BOSTON SCIENTIFIC CORP (BSX) is a surgical & medical instruments & apparatus company, incorporated in DE. BOSTON SCIENTIFIC CORP trades on BSX: NYSE as: BSX. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), BOSTON SCIENTIFIC CORP reported a 17.43% year-over-year revenue growth, a Gross Profit Margin of 69.17% (TTM), a Debt-to-Equity ratio of 0.18x, a Price-to-Sales (P/S) ratio of 4.52x (TTM), a Price-to-Book (P/B) ratio of 3.57 (TTM), at a market cap of $93.18B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 17.43%
Gross Profit Margin TTM: 69.17%
Debt To Equity: 0.18x
P/S TTM: 4.52x
P/B TTM: 3.57
Market Cap: $93.18B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is BOSTON SCIENTIFIC CORP in?

BOSTON SCIENTIFIC CORP (BSX) operates in the Surgical & Medical Instruments & Apparatus industry.

What is BSX's market cap?

BOSTON SCIENTIFIC CORP (BSX) has a market capitalization of $93.18B as of 2026-03-31.

What is BSX's P/E ratio?

BOSTON SCIENTIFIC CORP (BSX)'s trailing twelve month P/E ratio is 26.15x as of 2026-03-31.

What exchange does BSX trade on?

BOSTON SCIENTIFIC CORP (BSX) trades on the BSX: NYSE.

Where is BOSTON SCIENTIFIC CORP incorporated?

BOSTON SCIENTIFIC CORP is incorporated in DE.

BOSTON SCIENTIFIC CORP (BSX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.